Children's Health

Host Michel Martin speaks with parent Jonathan Kealing, whose young son participated in Moderna vaccine trials this summer.

Children between the ages of 5 and 11 can now get the Pfizer coronavirus vaccine. We visit a vaccination site in Washington, D.C., to hear from kids about why they're getting the jab.

Kids who need hormone-blocking drugs to prevent premature puberty — or delay it if they're trans — have lost a more affordable option. The remaining nearly identical drug costs eight times more.

The first vaccine required for school was for smallpox, over 200 years ago. And for decades, all states have required that kids be vaccinated against contagious diseases like polio to attend school.

After months of waiting, many parents of kids ages 5 to 11 expressed relief and joy when the CDC gave its recommendation for Pfizer's vaccine to be made available to that age group.

Parents react to the recent Food and Drug Administrations emergency use authorization for the Pfizer vaccine, which allows children ages 5-11 to receive the vaccine.

Physicians weigh in on what you need to know about the safety and efficacy of the vaccine, and how to think about the risks and benefits of vaccinating your kid

Kids ages 5 to 11 will soon be able to get Pfizer's low-dose COVID vaccine. CDC director Rochelle Walensky agreed with a unanimous decision of a team of advisers that the benefits outweigh the risks.

School-aged children are now eligible for Pfizer's COVID-19 vaccine, as CDC director Rochelle Walensky issued the recommendation supporting this version of the vaccine.

The country nearly eradicated this treatable sexually transmitted disease twice, only to see it come roaring back. The failure shows the weakness of a cash-strapped public health system.

The open enrollment period to buy health insurance on HealthCare.gov starts now and runs through Jan. 15, 2022. Look for more options and expanded subsidies this year — and more help signing up.

Children ages 5-11 are a step closer to being eligible for the Pfizer COVID vaccine. It's a lower-dose formulation and expected to go to an advisory panel of the CDC next.